Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma...

  • Main
  • 2016 / 08
  • Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma...

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous stem cell transplant: a cost-effectiveness analysis in Scotland

Parker, Christopher, Woods, Beth, Eaton, James, Ma, Esprit, Selby, Ross, Benson, Eugene, Engstrom, Andreas, Sajosi, Peter, Briggs, Andrew, Bonthapally, Vijayveer
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.1080/13696998.2016.1219358
Date:
August, 2016
File:
PDF, 845 KB
english, 2016
Conversion to is in progress
Conversion to is failed